The breast implants are associated with a rare cancer. Market Pull Required

The American Administration for Barnats and Foods (FDA) has called on Alergan Bay implant designers to withdraw porn surface implants from the market after connecting to a rare type of cancer.

Worldwide, 573 cases and 33 cancer deaths have been reported, with 481 of these cancer-diagnosed cases being directly attributed to Allergan Biocelli implants, the FDA says. Of the 33 deaths, the agency says its data shows that this type of implant has been used in 13 of the cases, while in 12 of them the producer has been Allergan.

Diana Zuckerman, a researcher who has taken care of breast implant security, described the removal of Allergan products as inevitable.

The company will regularly decide to remove or the FDA will force Allergan to do it. ”

The disease is an analysmic lymphoma with large cells, a rare type of immune system cancer. It's not breast cancer, but it develops in the tissue around the implant.

If the implant and damaged tissue are removed, cancer may be treated, but if not discovered early, it can spread and cause more serious problems to the point of death. Enhancing the breasts is one of the most popular plastic surgery in the United States, where more than 300 thousand operations were performed in 2017, 3% more than in 2016.

Source Layer: The New York Times